Polyethyleneimine-based drug delivery systems for cancer theranostics
C Zhao, B Zhou - Journal of Functional Biomaterials, 2022 - mdpi.com
With the development of nanotechnology, various types of polymer-based drug delivery
systems have been designed for biomedical applications. Polymer-based drug delivery …
systems have been designed for biomedical applications. Polymer-based drug delivery …
Immunogenic chemotherapy: great potential for improving response rates
X Huang, Q Ren, L Yang, D Cui, C Ma, Y Zheng… - Frontiers in …, 2023 - frontiersin.org
The activation of anti-tumor immunity is critical in treating cancers. Recent studies indicate
that several chemotherapy agents can stimulate anti-tumor immunity by inducing …
that several chemotherapy agents can stimulate anti-tumor immunity by inducing …
[HTML][HTML] Lutein-loaded chitosan/alginate-coated Fe3O4 nanoparticles as effective targeted carriers for breast cancer treatment
Magnetic drug targeting can be a strategy for effectively delivering phytochemicals in cancer
treatment. Here, we demonstrate the benefit of magnetic targeting with superparamagnetic …
treatment. Here, we demonstrate the benefit of magnetic targeting with superparamagnetic …
The Fate of Water in Hydrogen‐Based Iron Oxide Reduction
Gas–solid reactions are important for many redox processes that underpin the energy and
sustainability transition. The specific case of hydrogen‐based iron oxide reduction is the …
sustainability transition. The specific case of hydrogen‐based iron oxide reduction is the …
[HTML][HTML] HER2-targeting two-dimensional black phosphorus as a nanoplatform for chemo-photothermal therapy in breast cancer
Y Liang, J Liu, C Zhao, H Sun, K Huang, Q Xie… - Materials Today Bio, 2023 - Elsevier
Trastuzumab (Tmab) targeted therapy or its combination with chemotherapy is normally
insufficient to elicit a comprehensive therapeutic response owing to the inherent or acquired …
insufficient to elicit a comprehensive therapeutic response owing to the inherent or acquired …
[HTML][HTML] Puzzling out iron complications in cancer drug resistance
M Abedi, S Rahgozar - Critical Reviews in Oncology/Hematology, 2022 - Elsevier
Iron metabolism are frequently disrupted in cancer. Patients with cancer are prone to anemia
and receive transfusions frequently; the condition which results in iron overload, contributing …
and receive transfusions frequently; the condition which results in iron overload, contributing …
Immunogenic chemotherapy: great potential for improving
X Huang¹, Q Ren²t, L Yang, D Cui⁴… - … Tumors-From the …, 2024 - books.google.com
Conventional chemotherapy agents are relatively inexpensive and widely used in treating
cancers in clinics. Clinicians usually have extensive knowledge of the toxicity profiles …
cancers in clinics. Clinicians usually have extensive knowledge of the toxicity profiles …